tradingkey.logo

Zymeworks Inc <ZYME.OQ> expected to post a loss of 41 cents a share - Earnings Preview

ReutersMay 6, 2025 8:32 PM
  • Zymeworks Inc ZYME.OQ ZYME.O is expected to show a rise in quarterly revenue when it reports results on May 8 for the period ending March 31 2025

  • The Middletown Delaware-based company is expected to report a 105.9% increase in revenue to $20.653 million from $10.03 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Zymeworks Inc is for a loss of 41 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Zymeworks Inc is $19.50​, above​ its last closing price of $12.85. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.17

-0.10

-0.31

Missed

-213.1

Sep. 30 2024

-0.31

-0.40

-0.39

Beat

1.4

Jun. 30 2024

-0.33

-0.32

-0.27

Beat

14.7​

Mar. 31 2024

-0.29

-0.29

-0.42

Missed

-44.8

​​Dec. 31 2023

-0.46

-0.43

-0.20

Beat

53.9

Sep. 30 2023

-0.50

-0.47

-0.41

Beat

12.7​

Jun. 30 2023

-0.49

-0.47

-0.76

Missed

-61.6

Mar. 31 2023

-0.55

-0.54

-0.36

Beat

32.9

This summary was machine generated May 6 at 20:32 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI